PATENT CLAIM ANALYSIS

Application Number: 16011063
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "062000"]

Abstract:
The present invention provides dosing regimens for administering pharmacological chaperones to a subject in need thereof. The dosing regimens can be used to treat disorders caused by improper protein misfolding, such as lysosomal storage disorders.

Claim (Index 31):
A method for treatment of Fabry disease in a human patient in need thereof, the method comprising administering to the patient a therapeutically effective dose of 1-deoxygalactonojirimycin or a salt thereof, wherein the therapeutically effective dose provides a similar mean drug exposure (AUC) as orally administering 150 mg of migalastat hydrochloride every other day.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16011068', '15213920', '12597238', '14054369', '12855468']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8149987746821057
- 35 USC 102 Novelty (BERT): 0.6398037303123001
- Combined Prediction Score: 0.7974792702451252
- Mean Citation Score: 582.5836959999998
- Max Citation Score: 739.6668
- Similarity Product: 533.6511083391666

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test